EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in Ophthalmic Epigenetics and Implications for Epigenetic Therapies: A Review

Spencer M Moore, John B Christoforidis

Genes · 2023

DOI: 10.3390/genes14020417 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, 2023. Verfasst von Spencer M Moore und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology & Vision Science, University of Arizona College of Medicine-Tucson, Tucson, AZ 85711, USA. Hauptthemen laut MEDLINE: Retinal Degeneration, Macular Degeneration. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The epigenome represents a vast molecular apparatus that writes, reads, and erases chemical modifications to the DNA and histone code without changing the DNA base-pair sequence itself. Recent advances in molecular sequencing technology have revealed that epigenetic chromatin marks directly mediate critical events in retinal development, aging, and degeneration. Epigenetic signaling regulates retinal progenitor (RPC) cell cycle exit during retinal laminar development, giving rise to retinal ganglion cells (RGCs), amacrine cells, horizontal cells, bipolar cells, photoreceptors, and Müller glia. Age-related epigenetic changes such as DNA methylation in the retina and optic nerve are accelerated in pathogenic conditions such as glaucoma and macular degeneration, but reversing these epigenetic marks may represent a novel therapeutic target. Epigenetic writers also integrate environmental signals such as hypoxia, inflammation, and hyperglycemia in complex retinal conditions such as diabetic retinopathy (DR) and choroidal neovascularization (CNV). Histone deacetylase (HDAC) inhibitors protect against apoptosis and photoreceptor degeneration in animal models of retinitis pigmentosa (RP). The epigenome represents an intriguing therapeutic target for age-, genetic-, and neovascular-related retinal diseases, though more work is needed before advancement to clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinal DegenerationMacular DegenerationAnimalsRetinaRetinal Ganglion CellsEpigenesis, Genetic

Stichwörter der Autor:innen

epigeneticsretinal agingretinal degeneration

Autor:innen und Institutionen

  • Department of Ophthalmology & Vision Science, University of Arizona College of Medicine-Tucson, Tucson, AZ 85711, USA.
  • Retina Specialists of Southern Arizonam, Tucson, AZ 85712, USA.

Zitieren

APA

Moore, S. M., & Christoforidis, J. B. (2023). Advances in Ophthalmic Epigenetics and Implications for Epigenetic Therapies: A Review. Genes. https://doi.org/10.3390/genes14020417

Vancouver

Moore SM, Christoforidis JB. Advances in Ophthalmic Epigenetics and Implications for Epigenetic Therapies: A Review. Genes. 2023. doi:10.3390/genes14020417

BibTeX
@article{Moore2023,
  author = {Moore, Spencer M and Christoforidis, John B},
  title = {Advances in Ophthalmic Epigenetics and Implications for Epigenetic Therapies: A Review},
  journal = {Genes},
  year = {2023},
  doi = {10.3390/genes14020417}
}
Kostenlos starten →